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OBJECTIVE — To assess the incidence and trend of the metabolic syndrome phenotype in
adolescents from the Tehran Lipid and Glucose Study during 3.6 years of follow-up.
RESEARCH DESIGN AND METHODS — A total of 932 adolescents, aged 10–19
years, who had complete data and returned for reassessment 3.6 years later were investigated.
RESULTS — Prevalenceofmetabolicsyndromeatbaselineandafter3.6yearswas7.4and
6.7%, respectively, based on the Adult Treatment Panel (ATP) III deﬁnitions; 3.5 and 8.0%,
respectively, based on the International Diabetes Federation (IDF) deﬁnitions; 4.1 and
9.4%, respectively, based on the American Heart Association (AHA) deﬁnitions; and 13.6
and 13.4%, respectively, based on the National Health and Nutrition Examination Survey
(NHANES) deﬁnitions. Incidence rates were 5.2% (95% CI 3–6) based on ATP III, 6.8%
(5–8) based on IDF, 8.3% (6–10) based on AHA, and 8.8% (6–10) based on NHANES
deﬁnitions.
CONCLUSIONS — Incidence of metabolic syndrome is high in Tehranian adolescents.
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T
hemetabolicsyndrome,deﬁnedasa
group of risk factors, including obe-
sity, impaired glucose metabolism,
dyslipidemia, and hypertension, is asso-
ciated with a heightened risk for develop-
ing cardiovascular diseases and type 2
diabetes and an enhanced mortality from
allcauses(1–3).Theaimofthisstudywas
toassessincidenceandtrendofmetabolic
syndrome prevalence in adolescents of
the Tehran Lipid and Glucose Study
(TLGS) after 3.6 years of follow-up.
RESEARCH DESIGN AND
METHODS— This study was con-
ducted within the framework of the
TLGS, a prospective study performed in a
representative 15,005 individuals aged
3–85yearsandresidentsofonedistrictof
Tehran (4). Adolescents, aged 10–19
years, who had complete data and re-
turned for reassessment 3.6 years later
were included in this study. Subjects who
were pregnant or who were taking medi-
cations that affect serum lipids, blood
pressure, and carbohydrate metabolism
were excluded in the study. The ﬁnal
sampleconsistedof932adolescents,who
were ﬁrst assessed in 1999–2001 and re-
assessed in 2003–2005.
Details of the TLGS protocol and all
laboratory procedures were published
elsewhere (4). Overweight was deﬁned as
at or above the 95th percentile of BMI for
age. At risk for overweight was deﬁned as
at or above the 85th percentile but less
than the 95th percentile of BMI for age
(5).
In this study, pediatric deﬁnitions of
metabolic syndrome by the Third Report
of the National Cholesterol Education
Program (Adult Treatment Panel III [ATP
III]) (6), the International Diabetes Fed-
eration (IDF) (7), the American Heart As-
sociation (AHA) (8), and the National
HealthandNutritionExaminationSurvey
(NHANES) (9) were used.
RESULTS— Atotalof932adolescents
(530 [56.9%] girls and 402 [43.1%]
boys),meanage14.382.85years,were
studied. Prevalence of metabolic syn-
dromeaccordingtotheATPIIIatbaseline
was 7.4% (95% CI 5.7–9) and after 3.6
years of follow-up was 6.7% (5–8) (Table
1). There was a signiﬁcant association be-
tween metabolic syndrome prevalence
(accordingtoATPIIIcriteria)andBMI,as
57.9% of overweight adolescents had the
metabolic syndrome compared with
29.2% of adolescents at risk for over-
weight and 2.4% of adolescents with nor-
mal weight (P  0.0001).
High fasting triglycerides and low
HDL cholesterol were the most prevalent
components according to ATP III criteria
(38.4 and 41.6%, respectively), whereas
high fasting blood glucose (FBG) was the
least common (1%). Lowering the FBG
cut point from 110 to 100 mg/dl in-
creased the percentage of subjects who
met this standard from 1 to 7.6%, and
lowering waist circumference cut point
from the 90th percentile to the 75th per-
centile for sex and age increased the pro-
portion of subjects who met this standard
from 10.3 to 27.3%.
The logistic regression of metabolic
risks on metabolic syndrome incidence
(positive versus negative) was signi-
ﬁcant (likelihood ratio 
2  70.64,
P  0.0001). When BMI and waist
circumference were put in logistic regres-
sion, we found strong a association of
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
From the
1Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Science, Yazd, Iran; and
the
2EndocrineResearchCenter,ResearchInstituteforEndocrineSciences,ShahidBeheshtiUniversityof
Medical Sciences, Tehran, Iran.
Corresponding author: Fereidoun Azizi, azizi@endocrine.ac.ir.
Received 7 January 2010 and accepted 25 May 2010. Published ahead of print at http://care.
diabetesjournals.org on 2 June 2010. DOI: 10.2337/dc09-0023.
© 2010 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited, the use is educational and not for proﬁt, and the work is not altered. See http://creativecommons.
org/licenses/by-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Cardiovascular and Metabolic Risk
BRIEF REPORT
2110 DIABETES CARE, VOLUME 33, NUMBER 9, SEPTEMBER 2010 care.diabetesjournals.orgthese variables with metabolic syndrome
incidence. Overweight adolescents were
5.69 times as likely to develop metabolic
syndrome(95%CI2.31–13.96).Subjects
with waist circumference more than the
90th percentile for age and sex had 2.24
times more chance to develop metabolic
syndrome(95%CI1.01–4.97).Onlogis-
tic regression, no signiﬁcant association
was seen between FBG, triglycerides,
HDL cholesterol, blood pressure, and age
with metabolic syndrome incidence.
CONCLUSIONS — Findings from
this study show that prevalence of meta-
bolic syndrome in Tehranian adolescents
haschangedatfollow-up,accordingtoall
deﬁnitions except for the NHANES
deﬁnition.
The metabolic syndrome phenotype
was most common in overweight adoles-
cents, with a prevalence of 57.9% com-
pared with 29.2% of adolescents at risk
for overweight and only 2.4% of normal
weight. The difference in metabolic syn-
drome among overweight subjects was
noticeable and shows the importance of
overweight on the prevalence of meta-
bolic syndrome. In addition, adolescents
who were overweight were 5.69 times as
likely to develop metabolic syndrome.
This can indicate that metabolic syn-
drome is greatly conﬁned to overweight
adolescents.
The most common metabolic risks in
our subjects were high triglyceride and
low HDL cholesterol levels. These ﬁnd-
ings are in accordance with several previ-
ous studies conducted among children
and adults in our area (10). The high
prevalence of the metabolic syndrome
and high triglyceride levels in Iran and
otherAsiancountries(10,11)strengthens
the hypothetical ethnic predisposition to-
ward this type of dyslipidemia among
Asians (12). Diets with high trans-
unsaturated fat could lower HDL choles-
terol levels, increase triglyceride levels,
and impede metabolism of fatty acids.
Kelishadi et al. (13) indicated that the
poor quality of the consumed fat, being
rich in saturated and trans-fatty acids,
correlated with the high prevalence of
dyslipidemia among adolescents in Iran.
Inaddition,theyfoundthattheriskofthe
metabolic syndrome among children and
adolescents rose with the consumption of
solid hydrogenated fat and white-ﬂour
bread (14). These ﬁndings potentiate the
speculation that some food habits may
play a role in metabolic syndrome
development.
The high glucose level was the least
common metabolic risk according to ATP
IIIcriteria.Thisﬁndingsupportsachange
in the thought of the metabolic syndrome
from that of a single entity causally asso-
ciated with insulin resistance to one in
which the syndrome depicts several dis-
tinct but intercorrelated entities (12).
Nevertheless, when we lowered FBG cut
point from 110 to 100 mg/dl, the propor-
tion of subjects who met this amount in-
creased to 7.6%. This shift has also been
reportedintheDuncanStudy(15).These
results call into question of the utility of
theFBGcutpointsinpediatricdeﬁnitions
of metabolic syndrome.
Our ﬁndings show that prevalence
and incidence of metabolic syndrome, as
a major risk factor for chronic diseases, is
high in Tehranian adolescents. Preva-
lence and incidence of metabolic syn-
drome increased with the severity of
obesity and reached to nearly 60% in
overweight adolescents. We conclude
that health professionals and policy mak-
ers should concentrate on primary pre-
vention of childhood obesity and the
metabolic syndrome, especially in devel-
oping countries in nutrition transition,
which are facing an epidemic of chronic
diseases in the near future.
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